Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans.
We compared the clinical manifestations, laboratory and radiologic findings, and outcomes of eight patients with proven pulmonary cryptococcosis (PC) caused by capsule-deficient Cryptococcus neoformans with those of six patients with PC caused by capsule-intact Cr. neoformans. The presentations and outcomes did not differ significantly between the groups.
Torres
H A
HA
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Prieto
V G
VG
Raad
I I
II
Kontoyiannis
D P
DP
D000328:Adult; D000368:Aged; D000946:Antigens, Fungal / Q000097:blood*; D003453:Cryptococcosis / Q000382:microbiology* / Q000473:pathology; D003455:Cryptococcus neoformans / Q000378:metabolism / Q000472:pathogenicity*; D006801:Humans; D008168:Lung / Q000382:microbiology / Q000473:pathology; D008172:Lung Diseases, Fungal / Q000382:microbiology* / Q000473:pathology; D008875:Middle Aged; D011134:Polysaccharides / Q000097:blood*
D000946:Antigens, Fungal; D011134:Polysaccharides